Log in

NASDAQ:DOX - Amdocs Stock Price, Forecast & News

+0.03 (+0.04 %)
(As of 12/6/2019 08:39 AM ET)
Today's Range
Now: $69.30
50-Day Range
MA: $67.28
52-Week Range
Now: $69.30
Volume591,823 shs
Average Volume826,297 shs
Market Capitalization$9.67 billion
P/E Ratio17.03
Dividend Yield1.65%
Amdocs Limited, through its subsidiaries, provides software and services to the communications, pay TV, entertainment, and media industry service providers worldwide. The company offers amdocsONE a line of services designed for various stages of a service provider's lifecycle, including planning, delivery, implementation, and ongoing support, as well as consumer experience and monetization, media and digital, enterprise and connected society, service-driven network, and services and agile operation solutions. Read More…

Industry, Sector and Symbol

Industry Custom computer programming services
Sub-IndustryIT Consulting & Other Services
SectorComputer and Technology
Current SymbolNASDAQ:DOX
Phone1 314 212 7000



Sales & Book Value

Annual Sales$4.09 billion
Cash Flow$5.50 per share
Book Value$25.38 per share


Net Income$479.45 million


Market Cap$9.67 billion
Next Earnings Date2/4/2020 (Estimated)

Receive DOX News and Ratings via Email

Sign-up to receive the latest news and ratings for DOX and its competitors with MarketBeat's FREE daily newsletter.

Amdocs (NASDAQ:DOX) Frequently Asked Questions

What is Amdocs' stock symbol?

Amdocs trades on the NASDAQ under the ticker symbol "DOX."

How often does Amdocs pay dividends? What is the dividend yield for Amdocs?

Amdocs declared a quarterly dividend on Tuesday, November 12th. Investors of record on Tuesday, December 31st will be given a dividend of $0.285 per share on Friday, January 24th. This represents a $1.14 annualized dividend and a yield of 1.65%. The ex-dividend date of this dividend is Monday, December 30th. View Amdocs' Dividend History.

How were Amdocs' earnings last quarter?

Amdocs Limited (NASDAQ:DOX) released its quarterly earnings results on Tuesday, November, 12th. The technology company reported $1.08 EPS for the quarter, meeting the Zacks' consensus estimate of $1.08. The technology company earned $1.03 billion during the quarter, compared to analyst estimates of $1.03 billion. Amdocs had a net margin of 11.73% and a return on equity of 15.98%. The company's quarterly revenue was up 2.8% on a year-over-year basis. During the same period in the prior year, the firm earned $0.99 earnings per share. View Amdocs' Earnings History.

When is Amdocs' next earnings date?

Amdocs is scheduled to release their next quarterly earnings announcement on Tuesday, February 4th 2020. View Earnings Estimates for Amdocs.

What guidance has Amdocs issued on next quarter's earnings?

Amdocs updated its first quarter 2020 After-Hours earnings guidance on Monday, November, 25th. The company provided earnings per share (EPS) guidance of $1.02-1.08 for the period, compared to the Thomson Reuters consensus estimate of $1.11. The company issued revenue guidance of $$1.015-1.055 billion, compared to the consensus revenue estimate of $$1.04 billion.

What price target have analysts set for DOX?

2 brokers have issued 1 year price objectives for Amdocs' shares. Their forecasts range from $72.00 to $75.00. On average, they expect Amdocs' stock price to reach $73.50 in the next year. This suggests a possible upside of 6.1% from the stock's current price. View Analyst Price Targets for Amdocs.

What is the consensus analysts' recommendation for Amdocs?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Amdocs in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Amdocs.

Has Amdocs been receiving favorable news coverage?

News stories about DOX stock have been trending very positive this week, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Amdocs earned a media sentiment score of 3.5 on InfoTrie's scale. They also gave news articles about the technology company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the stock's share price in the near future. View News Stories for Amdocs.

Are investors shorting Amdocs?

Amdocs saw a decline in short interest during the month of November. As of November 15th, there was short interest totalling 2,190,000 shares, a decline of 5.6% from the October 31st total of 2,320,000 shares. Based on an average trading volume of 550,800 shares, the days-to-cover ratio is presently 4.0 days. Currently, 1.6% of the company's stock are sold short. View Amdocs' Current Options Chain.

Who are some of Amdocs' key competitors?

What other stocks do shareholders of Amdocs own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Amdocs investors own include QUALCOMM (QCOM), Home Depot (hd), Activision Blizzard (ATVI), Comcast (CMCSA), AbbVie (ABBV), Boeing (BA), Caterpillar (CAT), Enterprise Products Partners (EPD), AT&T (T) and Target (TGT).

Who are Amdocs' key executives?

Amdocs' management team includes the folowing people:
  • Mr. Joshua Sheffer, Pres & CEO (Age 59)
  • Ms. Tamar Rapaport-Dagim, CFO & COO (Age 48)
  • Mr. Matthew E. Smith, Sec. & Head of Investor Relations (Age 47)
  • Mr. Gary Miles, Chief Marketing Officer
  • Darcy Antonellis, Head of Amdocs Media

Who are Amdocs' major shareholders?

Amdocs' stock is owned by many different of retail and institutional investors. Top institutional investors include Massachusetts Financial Services Co. MA (3.05%), Beutel Goodman & Co Ltd. (2.08%), Boston Partners (1.61%), State Street Corp (1.40%), Robeco Institutional Asset Management B.V. (0.99%) and TimesSquare Capital Management LLC (0.82%).

Which major investors are selling Amdocs stock?

DOX stock was sold by a variety of institutional investors in the last quarter, including Massachusetts Financial Services Co. MA, TimesSquare Capital Management LLC, Beutel Goodman & Co Ltd., Man Group plc, Stifel Financial Corp, Squarepoint Ops LLC, First Trust Advisors LP and Voya Investment Management LLC.

Which major investors are buying Amdocs stock?

DOX stock was acquired by a variety of institutional investors in the last quarter, including Millennium Management LLC, Fisher Asset Management LLC, Russell Investments Group Ltd., State Street Corp, California Public Employees Retirement System, Zurcher Kantonalbank Zurich Cantonalbank, Robeco Institutional Asset Management B.V. and Phoenix Holdings Ltd..

How do I buy shares of Amdocs?

Shares of DOX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Amdocs' stock price today?

One share of DOX stock can currently be purchased for approximately $69.30.

How big of a company is Amdocs?

Amdocs has a market capitalization of $9.67 billion and generates $4.09 billion in revenue each year. The technology company earns $479.45 million in net income (profit) each year or $4.07 on an earnings per share basis. Amdocs employs 24,381 workers across the globe.View Additional Information About Amdocs.

What is Amdocs' official website?

The official website for Amdocs is http://www.amdocs.com/.

How can I contact Amdocs?

Amdocs' mailing address is 1390 Timberlake Manor Parkway, Chesterfield MO, 63017. The technology company can be reached via phone at 1 314 212 7000 or via email at [email protected]

MarketBeat Community Rating for Amdocs (NASDAQ DOX)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  546 (Vote Outperform)
Underperform Votes:  430 (Vote Underperform)
Total Votes:  976
MarketBeat's community ratings are surveys of what our community members think about Amdocs and other stocks. Vote "Outperform" if you believe DOX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DOX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/6/2019 by MarketBeat.com Staff

Featured Article: Stock Portfolio Tracker

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel